NovoCure Ltd — Director's Dealing 2018

Dec 12, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NovoCure Ltd (NVCR)
CIK: 0001645113
Period of Report: 2017-12-10

Reporting Person: LEUNG GABRIEL (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-12-10	Ordinary Shares	M	5000	$3.44	Acquired	65000	Direct
2018-12-10	Ordinary Shares	S	5000	$33.49	Disposed	60000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-12-10	Options to Buy Ordinary Shares	$3.44	M	5000	Acquired	2021-09-14	Ordinary Shares (5000)	Direct

Footnotes

F1: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Mr. Leung.

F2: Options to buy 5,000 ordinary shares are vested and currently exercisable as of the date hereof.